Troponin I and T and Adverse Outcomes in Patients With and Without Diabetes Mellitus After Coronary Intervention

A Sex-specific Analysis of the Predictive Value of Troponin I and T in Patients With and Without Diabetes Mellitus After Successful Coronary Intervention

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03627455

Enrollment

818

Registered

2018-08-13

Start date

2003-01-01

Completion date

2017-12-31

Last updated

2018-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Diabetes Mellitus

Brief summary

Elevated levels of troponin are associated with future MACE. Data on the prognostic value of high sensitive troponin T (hs-TnT) as compared to high sensitive troponin I (hs-TnI) in diabetic and non-diabetic patients are sparse. We aimed to assess the risk for MACE according to gender and diabetes status and to compare the prognostic value of hs-TnT and hs-TnI with regards to clinical outcomes in diabetic and non-diabetic patients undergoing percutaneous coronary intervention (PCI).

Interventions

OTHERPercutaneous coronary intervention

Percutaneous coronary intervention

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Percutaneous coronary intervention

Exclusion criteria

* unsuccessful percutaneous coronary intervention

Design outcomes

Primary

Measure	Time frame	Description
MACE	8 years	All-cause death, non-fatal myocardial infarction, non-fatal stroke

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026